File #: A 20-127    Name: Bard Medical Division C.R. Bard, Inc. Amendment No. 1
Type: BoS Agreement Status: Passed - Natividad Medical Center
File created: 5/8/2020 In control: Board of Supervisors
On agenda: 6/9/2020 Final action: 6/9/2020
Title: Authorize the Deputy Purchasing Agent for Natividad Medical Center (NMC) or his designee to execute amendment No. 1 to the agreement with Bard Medical Division C.R. Bard, Inc. for purchase of medical device products and support services, adding $60,424 for a revised total agreement amount not to exceed $130,424, with no change to the term of the agreement May 1, 2018 through April 23, 2023.
Attachments: 1. Board Report, 2. Bard Medical Division C.R. Bard Inc. Amendment 1, 3. Bard Medical Division C.R. Bard Inc. Agreement, 4. Item No. 16 Completed Board Order
Title
Authorize the Deputy Purchasing Agent for Natividad Medical Center (NMC) or his designee to execute amendment No. 1 to the agreement with Bard Medical Division C.R. Bard, Inc. for purchase of medical device products and support services, adding $60,424 for a revised total agreement amount not to exceed $130,424, with no change to the term of the agreement May 1, 2018 through April 23, 2023.
Report
RECOMMENDATION:

It is recommended the Board of Supervisors:

Authorize the Deputy Purchasing Agent for Natividad Medical Center (NMC) or his designee to execute amendment No. 1 to the agreement with Bard Medical Division C.R. Bard, Inc. for purchase of medical device products and support services, adding $60,424 for a revised total agreement amount not to exceed $130,424, with no change to the term of the agreement May 1, 2018 through April 23, 2023.

SUMMARY/DISCUSSION:

The services received will ensure therapeutic hypothermia for sudden cardiac arrest (SCA), which is a class I Advanced Cardiac Life Support (ACLS) guideline recommendation. The only other class I guideline for SCA patients is CPR and Defibrillation; this is the standard of care and must be offered to all applicable patients.

The services are beneficial to NMC because it is imperative that hospital systems have the option to initiate treatment quickly and to meet the 2015 American Heart Association Class IA recommendation for Targeted Temperature Management (TTM). TTM is challenging to administer properly through conventional means because there are four distinct phases of treatment which requires the clinical team to control and maintain over 4-5 days, and it all must be done while the critical care patient travels between multiple departments within the hospital (i.e. ER, Cath Lab and ICU). The goal is to slow down the metabolic demand by reducing core temperature of the patient after ROSC per AHA guidelines.

The services are beneficial to patients because current water blanket system...

Click here for full text